Gene expression signature of Gleason score is associated with prostate cancer outcomes in a radical prostatectomy cohort

Min A. Jhun, Milan S. Geybels, Jonathan L. Wright, Suzanne Kolb, Craig April, Marina Bibikova, Elaine A. Ostrander, Jian-Bing Fan, Ziding Feng, Janet L. Stanford*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)43035-43047
Number of pages13
JournalOncotarget
Volume8
Issue number26
DOIs
Publication statusPublished - 27 Jun 2017

Keywords

  • gene expression
  • Gleason score
  • prostate cancer
  • recurrence
  • metastasis
  • NEEDLE-BIOPSY COHORT
  • GENOMIC CLASSIFIER
  • BIOCHEMICAL RECURRENCE
  • RISK STRATIFICATION
  • METASTATIC-DISEASE
  • PROGRESSION
  • VALIDATION
  • POPULATION
  • CARCINOMA
  • DEATH

Cite this

Jhun, M. A., Geybels, M. S., Wright, J. L., Kolb, S., April, C., Bibikova, M., Ostrander, E. A., Fan, J-B., Feng, Z., & Stanford, J. L. (2017). Gene expression signature of Gleason score is associated with prostate cancer outcomes in a radical prostatectomy cohort. Oncotarget, 8(26), 43035-43047. https://doi.org/10.18632/oncotarget.17428